Company Profile
Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high performance enzymes and biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of small molecule pharmaceuticals, in RNA and DNA synthesis and the creation of next generation life science tools, and as gene therapies and oral enzyme therapies. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved return on capital in manufacturing, improved sensitivity in genomic and diagnostic applications, and more efficacious therapeutics.
Latest Presentation
Industry Classifications
Sector:
Healthcare
Industry:
Biotechnology
NAICS:
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC:
Commercial Physical and Biological Research (8731)
Contact Information
Investor Relations
Codexis, Inc.
Carrie McKim
200 Penobscot Drive
Redwood City, CA 94063
T: 650-421-8106
ir@codexis.com
Company Contact
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States
T: (650) 421-8100
media@codexis.com